Natural Alternatives International Inc: Form 10-Q for the period ended Dec 31, 2023
Filed with the SEC on Feb 13, 2024 and accepted by EDGAR at Feb 13, 2024, 16:15 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2023-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2023-10-01 to 2023-12-31 | $25.2m | us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax |
| Revenue | 6 months2023-07-01 to 2023-12-31 | $59.2m | us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax |
| Cost of revenue | 3 months2023-10-01 to 2023-12-31 | $24.8m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 6 months2023-07-01 to 2023-12-31 | $55.6m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months2023-10-01 to 2023-12-31 | $387.0k | us-gaap:GrossProfit |
| Gross profit | 6 months2023-07-01 to 2023-12-31 | $3.5m | us-gaap:GrossProfit |
| Selling, general and administrative | 3 months2023-10-01 to 2023-12-31 | $3.9m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 6 months2023-07-01 to 2023-12-31 | $7.6m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2023-10-01 to 2023-12-31 | −$3.5m | us-gaap:OperatingIncomeLoss |
| Operating income | 3 months2023-10-01 to 2023-12-30 | −$3.5m | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months2023-07-01 to 2023-12-31 | −$4.1m | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months2023-07-01 to 2023-12-30 | −$4.1m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months2023-10-01 to 2023-12-31 | −$761.0k | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months2023-07-01 to 2023-12-31 | −$950.0k | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2023-10-01 to 2023-12-31 | −$3.1m | us-gaap:NetIncomeLoss |
| Net income | 6 months2023-07-01 to 2023-12-31 | −$3.8m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2023-10-01 to 2023-12-31 | −$0.52 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months2023-07-01 to 2023-12-31 | −$0.64 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2023-10-01 to 2023-12-31 | −$0.52 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months2023-07-01 to 2023-12-31 | −$0.64 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2023-10-01 to 2023-12-31 | 5,850,131 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months2023-07-01 to 2023-12-31 | 5,850,131 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months2023-07-01 to 2023-12-31 | $4.8m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 6 months2023-07-01 to 2023-12-31 | $1.7m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Share repurchases | 6 months2023-07-01 to 2023-12-31 | $0 | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2023-12-31 | $16.6m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2023-12-31 | $54.4m | us-gaap:AssetsCurrent |
| Total assets | At period end2023-12-31 | $155.7m | us-gaap:Assets |
| Total assets | At period end2023-12-30 | $155.7m | us-gaap:Assets |
| Current liabilities | At period end2023-12-31 | $13.4m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2023-12-31 | $70.3m | us-gaap:Liabilities |
| Shareholders' equity | At period end2023-12-31 | $85.5m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001437749-24-003906. Last ingested by Listed: Oct 24, 2026, 14:56 ET. Listed shows no prices and gives no investment advice.